EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 7 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 11.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,780 | +10.3% | 401,847 | -3.6% | 0.01% | 0.0% |
Q2 2023 | $7,963 | +46.3% | 416,785 | +48.6% | 0.01% | +150.0% |
Q1 2023 | $5,444 | -20.7% | 280,471 | -34.5% | 0.00% | -33.3% |
Q4 2022 | $6,865 | -99.9% | 427,884 | +25.0% | 0.00% | -50.0% |
Q3 2022 | $5,369,000 | -59.3% | 342,442 | -46.0% | 0.01% | -25.0% |
Q2 2022 | $13,195,000 | +386.4% | 633,783 | +429.6% | 0.01% | +300.0% |
Q1 2022 | $2,713,000 | -2.0% | 119,680 | -21.0% | 0.00% | +100.0% |
Q4 2021 | $2,768,000 | -25.8% | 151,564 | -14.1% | 0.00% | -50.0% |
Q3 2021 | $3,732,000 | -53.1% | 176,510 | -59.6% | 0.00% | -50.0% |
Q2 2021 | $7,954,000 | +68.6% | 436,559 | +109.0% | 0.00% | +33.3% |
Q1 2021 | $4,717,000 | +397.0% | 208,831 | +341.7% | 0.00% | – |
Q4 2020 | $949,000 | -66.4% | 47,276 | -59.1% | 0.00% | -100.0% |
Q3 2020 | $2,823,000 | -30.6% | 115,462 | -32.6% | 0.00% | -66.7% |
Q2 2020 | $4,069,000 | -75.8% | 171,377 | -82.4% | 0.00% | -76.9% |
Q1 2020 | $16,802,000 | +94.5% | 975,732 | +99.0% | 0.01% | +160.0% |
Q4 2019 | $8,640,000 | -8.3% | 490,345 | -8.0% | 0.01% | 0.0% |
Q3 2019 | $9,422,000 | -1.0% | 532,733 | +19.6% | 0.01% | -16.7% |
Q2 2019 | $9,520,000 | +151.2% | 445,509 | +179.7% | 0.01% | +100.0% |
Q1 2019 | $3,790,000 | -53.1% | 159,253 | -61.2% | 0.00% | -50.0% |
Q4 2018 | $8,078,000 | -9.5% | 410,700 | -18.4% | 0.01% | 0.0% |
Q3 2018 | $8,923,000 | -29.1% | 503,504 | -13.9% | 0.01% | -45.5% |
Q2 2018 | $12,587,000 | -2.5% | 584,819 | +0.3% | 0.01% | +10.0% |
Q1 2018 | $12,912,000 | -7.1% | 582,934 | +27.5% | 0.01% | -9.1% |
Q4 2017 | $13,894,000 | +52.8% | 457,042 | +21.8% | 0.01% | +10.0% |
Q3 2017 | $9,090,000 | +29.0% | 375,172 | +31.2% | 0.01% | +42.9% |
Q2 2017 | $7,045,000 | +126.5% | 286,042 | +99.3% | 0.01% | +75.0% |
Q1 2017 | $3,110,000 | -15.5% | 143,536 | -41.9% | 0.00% | 0.0% |
Q4 2016 | $3,681,000 | -13.1% | 246,872 | -25.5% | 0.00% | -20.0% |
Q3 2016 | $4,237,000 | +105.0% | 331,198 | +25.1% | 0.01% | +66.7% |
Q2 2016 | $2,067,000 | +64.4% | 264,660 | -15.8% | 0.00% | +50.0% |
Q1 2016 | $1,257,000 | +39.0% | 314,237 | +73.7% | 0.00% | +100.0% |
Q4 2015 | $904,000 | -30.7% | 180,911 | -30.7% | 0.00% | 0.0% |
Q3 2015 | $1,305,000 | +88.0% | 260,913 | +12.6% | 0.00% | – |
Q2 2015 | $694,000 | -61.3% | 231,783 | -74.1% | 0.00% | -100.0% |
Q1 2015 | $1,791,000 | +345.5% | 894,649 | +122.9% | 0.00% | – |
Q4 2014 | $402,000 | +10.4% | 401,314 | +10.0% | 0.00% | – |
Q3 2014 | $364,000 | -71.7% | 364,861 | -14.9% | 0.00% | -100.0% |
Q2 2014 | $1,286,000 | -17.5% | 428,584 | -17.5% | 0.00% | 0.0% |
Q1 2014 | $1,559,000 | +147.9% | 519,471 | +395.8% | 0.00% | – |
Q4 2013 | $629,000 | +5.4% | 104,771 | -12.2% | 0.00% | – |
Q3 2013 | $597,000 | +8.0% | 119,300 | -2.1% | 0.00% | – |
Q2 2013 | $553,000 | – | 121,903 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |